RAVERA, Mauro
 Distribuzione geografica
Continente #
NA - Nord America 5.105
EU - Europa 4.757
AS - Asia 2.736
SA - Sud America 594
AF - Africa 86
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 5
Totale 13.293
Nazione #
US - Stati Uniti d'America 4.969
IE - Irlanda 1.384
SG - Singapore 865
DE - Germania 819
SE - Svezia 690
CN - Cina 643
HK - Hong Kong 565
UA - Ucraina 544
BR - Brasile 472
FI - Finlandia 350
IT - Italia 350
RU - Federazione Russa 328
VN - Vietnam 287
IN - India 130
CA - Canada 99
GB - Regno Unito 91
FR - Francia 62
KR - Corea 54
AR - Argentina 53
BJ - Benin 40
IR - Iran 37
ID - Indonesia 35
BD - Bangladesh 31
MX - Messico 29
PL - Polonia 29
EC - Ecuador 27
BE - Belgio 22
TR - Turchia 21
ZA - Sudafrica 20
ES - Italia 19
JP - Giappone 19
AT - Austria 15
LT - Lituania 14
EG - Egitto 12
RO - Romania 11
EU - Europa 10
NL - Olanda 10
CL - Cile 9
PY - Paraguay 9
UZ - Uzbekistan 9
CO - Colombia 8
VE - Venezuela 8
SA - Arabia Saudita 7
MA - Marocco 6
AL - Albania 5
PK - Pakistan 5
AU - Australia 4
IL - Israele 4
IQ - Iraq 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
HR - Croazia 3
NP - Nepal 3
PE - Perù 3
TN - Tunisia 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
JO - Giordania 2
PA - Panama 2
RS - Serbia 2
BG - Bulgaria 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
ML - Mali 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
UG - Uganda 1
Totale 13.293
Città #
Dublin 1.376
Jacksonville 988
Hong Kong 564
Dearborn 542
Singapore 320
Beijing 298
Ashburn 267
Chandler 253
Wilmington 237
New York 214
Lawrence 173
Princeton 173
Ann Arbor 160
Los Angeles 160
Moscow 138
San Mateo 128
Andover 108
Piemonte 104
Ho Chi Minh City 103
Buffalo 87
Munich 80
Toronto 55
Hanoi 54
Seoul 54
São Paulo 52
Grafing 48
Bremen 43
Novara 41
Cotonou 40
Dallas 40
Redondo Beach 37
Santa Clara 33
Helsinki 32
Hefei 30
Nanjing 28
Denver 27
Frankfurt am Main 25
Houston 25
Montreal 25
Woodbridge 25
Kunming 23
Monmouth Junction 22
Atlanta 21
Boardman 21
Norwalk 21
Stockholm 21
Brussels 20
Leawood 20
Warsaw 20
Cave Creek 19
Tokyo 19
Brooklyn 18
Orem 18
London 17
Rio de Janeiro 17
Zanjan 16
Biên Hòa 14
Nuremberg 14
Chennai 13
Chicago 13
Fairfield 13
Mexico City 13
Ardabil 12
Da Nang 12
Turin 12
Augusta 11
Belo Horizonte 11
Guangzhou 11
Haiphong 11
Jinan 11
Kocaeli 11
Mumbai 11
Poplar 11
Turku 11
Boston 10
Brasília 10
Guayaquil 10
Hebei 10
Jakarta 10
Johannesburg 10
Milan 10
Seattle 10
Campinas 9
Ninh Bình 9
Quito 9
Shenyang 9
Tashkent 9
Thái Bình 9
Wuhan 9
Ankara 8
Bexley 8
Hải Dương 8
Manchester 8
Salvador 8
Tianjin 8
Vienna 8
Cairo 7
Düsseldorf 7
Fortaleza 7
Sacramento 7
Totale 7.942
Nome #
Antiproliferative Activity of Pt(IV) Conjugates Containing the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Ketoprofen and Naproxen 134
Cisplatin and valproate released from the bifunctional [Pt(IV)Cl2(NH3)2(valproato)2] antitumor prodrug or from liposome formulations: who does what? 126
Transition metal carbonyl clusters in biology: A futile or niche research area? 122
Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells 120
Antiproliferative Pt(IV) complexes: synthesis, biological activity, and quantitative structure-activity relationship modeling 117
Assessment of the anticancer potentiality of a new platinum nanoparticulate coniugate 116
Antiproliferative Activity of PtII Complexes with Carboxylated Phosphanes in Chelated or Ring-Opened Forms 116
Beyond the Pt(II)-based chemotherapy: Pt(IV) complexes as oral anticancer pro-drugs 114
Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs 114
Different strategies to exploit Pt(IV) complexes as pro-drugs 113
Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs 110
The antiproliferative activity of dicobalt-hexacarbonyl-aspirin complex on different malignant pleural mesotelioma phenotypes 108
A different way for the oxidation of the Pt(II) complexes 108
A New Entry to Asymmetric Platinum(IV) Complexes via Oxidative Chlorination 107
Moving the paradigm in platinum-based chemotherapy from Pt(II) to Pt(IV) complexes? 105
Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 105
Appraisal of the Redox Behaviour of the Antimetastatic Ruthenium(III) Complex [ImH][RuCl4(DMSO)(Im)], NAMI-A 104
Experimental (RP-HPLC) and theoretical (MIFs) study of the lipophilicity of a series of Pt(IV) complexes 102
A step towards development of promising trypanocidal agents: Synthesis, characterization and in vitro biological evaluation of ferrocenyl Mannich base-type derivatives 102
Estradiol as Carrier For Selective Delivery of Cytotoxic Pt(II) Complexes to Cancer Cell Nuclei 101
Cytotoxicity of some Pt(II)-diamine complexes: a QSAR evaluation of the effect of chelating arms and leaving groups 101
Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer 101
Host-guest inclusion systems of Pt(IV)-bis(benzoato) anticancer drug candidates and cyclodextrins 99
Functionalized nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 99
Application of microwave-assisted heating to the synthesis of Pt(II) complexes 99
Antitumor platinum(IV) pro-drugs: synthesis, characterization, cytotoxicity and QSAR analysis 98
New Platinum-Based Prodrug Pt(IV)Ac-POA: Antitumour Effects in Rat C6 Glioblastoma Cells 98
Study of the synthesis, antiproliferative properties, and interaction with DNA and polynucleotides of cisplatin-like Pt(II) complexes containing carcinogenic polyaromatic amines 97
The cisplatin-based Pt(IV)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions 97
Experimental and molecular modeling approaches to determine the lipophilicity of a Pt(IV) pro-drugs 96
Electrochemical measurements confirm the preferential bonding of the antimetastatic complex [ImH][RuCl(4)(DMSO)(Im)] (NAMI-A) with proteins and the weak interaction with nucleobases 96
Hybrid inorganic (nonporous silica)/organic (alginate) core-shell platform for targeting a cisplatin-based Pt(IV) anticancer prodrug 96
Effects of dimethylsulfoxide and ethanol on the cytotoxic activity of titanocene dichloride 94
Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: How long the organic chain should be? 93
Polyanionic Biopolymers for the Delivery of Pt(II) Cationic Antiproliferative Complexes 93
A view on multi-action Pt(IV) antitumor prodrugs 93
Oxidative degradation of 1,5-naphthalenedisulfonic acid (NDS) in aqueous solutions by microwave irradiation in the presence of H2O2 92
Solvolysis of a Series of Cisplatin-Like Complexes – Comparison between DNA-Biosensor and Conductivity Data 92
Cis,cis,trans-[PtIVCl2(NH3)2(perillato)2], a dual-action prodrug with excellent cytotoxic and antimetastatic activity 92
Synthesis, characterization and antiproliferative activity of platinum(IV) derivates of picoplatin 91
How to obtain Pt(IV) complexes suitable for conjugation to nanovectors from the oxidation of [PtCl(terpyridine)]+ 90
Synthesis and characterization of cyclohexane-1R,2R-diamine-based Pt(iv) dicarboxylato anticancer prodrugs: their selective activity against human colon cancer cell lines 89
Bifunctional Pt-ethacrynic acid conjugates for malignant mesothelioma 88
Classical Pt(II) anticancer complexes revised in view of drug targeting and delivery 88
May glutamine addiction drive the delivery of antitumor cisplatin-based Pt(IV) prodrugs? 88
An unsymmetric cisplatin-based Pt(IV) derivative containing 2-(2-propynyl)octanoate: A very efficient multi-action antitumor prodrug candidate 88
Anthracene-terpyridine metal complexes as new G-quadruplex DNA binders 87
Evaluation of Platinum–Ethacrynic Acid Conjugates in the Treatment of Mesothelioma 86
Synthesis of PtIV-Biomolecule Conjugates through Click Chemistry 86
Application of the anthraquinone drug rhein as an axial ligand in bifunctional Pt(iv) complexes to obtain antiproliferative agents against human glioblastoma cells 85
Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin 85
Unprecedented one-pot synthesis of an unsymmetrical cisplatin-based Pt(IV)-acetamidato complex 85
Pt(IV)/Re(I) Chitosan Conjugates as a Flexible Platform for the Transport of Therapeutic and/or Diagnostic Anticancer Agents 84
Electronic Communication in [Co2(CO)6]2-diyne and [Co2(CO)4(dppm)]2-diyne Complexes 83
Pyrazolyl-diamine Pt(II) complexes bearing DNA-intercalating moieties: Synthesis, characterization and in vitro evaluation 83
An experiment in the electrokinetic removal of copper from soil contaminated by the brass industry 83
Pros and cons of bifunctional platinum drugs: two are (not always) better than one 83
Two are (not always) better than one: the case of bifunctional platinum(IV) drugs 83
Pt(IV) complexes as anticancer prodrugs 83
The hexacarbonyldicobalt derivative of aspirin acts as a CO-releasing NSAID on malignant mesothelioma cells 83
Bidentate and tridentate pyrazolyl-containing Pt(II) complexes: synthesis, characterization and in vitro evaluation 81
Pt(IV) – histone deacetylase inhibitor conjugates for citotoxicity studies on MPM cells 81
Freshening up Old Methods for New Students: A Colorful Laboratory Experiment to Measure the Formation Constants of Ni(II) Complexes Containing Ethane-1,2-Diamine 80
Bifunctional Ethacrynic Acid – Pt Conjugates: In vitro Treatment of Malignant Pleural Mesothelioma 79
A comparative study of the effects of platinum(II) complexes on β-amyloid aggregation: Potential neurodrug applications 79
Synthesis and in-vitro cytotoxicity of cis,cis,trans-diammine dichlorido disuccinatoplatinum(IV)-peptide bioconjugates 78
Oxidative degradation of 1,5-naphthalenedisulfonic acid in aqueous solutions by UV-photolysis in the absence and presence of H2O2 78
Prediction of logP for Pt(II) and Pt(IV) complexes: Comparison of statistical and quantum-chemistry based approaches 78
Molecular Interaction Fields vs. Quantum-Mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexes 77
Bioinorganic chemistry: the study of the fate of platinum-based antitumour drugs 76
Electrochemical Behavior of the Electronically and Coordinatively Unsaturated [Os3(µ-H)(CO)8{Ph2PCH2P(Ph)C6H4}] Cluster 75
Metallo-drugs in the Treatment of Malignant Pleural Mesothelioma 75
Can the Self-Assembling of Dicarboxylate Pt(IV) Prodrugs Influence Their Cell Uptake? 75
Pt(iv) complexes based on cyclohexanediamines and the histone deacetylase inhibitor 2-(2-propynyl)octanoic acid: synthesis, characterization, cell penetration properties and antitumor activity 73
Electron Interactions in Cluster Dimers. An Electrochemical Approach 72
Electron Interactions in Cluster Diynes. An Electrochemical Approach 72
The Stepwise Reduction of Dinitrogen Occurring on a Divanadium Model Compound: A Synthetic, Structural, Magnetic, Electrochemical and Theoretical Investigation on the [V=N=N=V]n+ [n = 4, 5, 6] Based Complexes 72
Solvolysis of Cisplatin and N-Methylated cis-[PtCl2(en)] Complexes – Comparison between DNA-Biosensor and Conductivity Data 71
The interaction between platinum(II) antiproliferative drugs and DNA evaluated by means of an electrochemical biosensor 71
Inhibition of telomerase activity by platinum derivatives 70
Experimental determination and modeling of the lipophilicity in platinum complexes 70
Conjugation between maleimide-containing Pt(IV) prodrugs and furan or furan-containing drug delivery vectors via Diels-Alder cycloaddition 70
Poly(methylmetacrylate) (PMMA) core-shell nanospheres act as efficient pharmacophores for the antiproliferative [PtCl3(NH3)]- complex by forming ionic couples 69
Pt(II) complexes with bidentate and tridentate pyrazolyl-containing chelators: synthesis, structural characterization and biological studies 69
The activation of platinum(II) antiproliferative drugs in carbonate medium evaluated by means of a DNA-biosensor 69
Functionalized thymidine derivatives as carriers for the γ-emitter technetium tricarbonyl moiety 68
Labeling of Proteins by a Triosmium Cluster via Bolton-Hunter-like Procedure 67
Estrogenic carriers for cytotoxic Pt(II) complexes: light and shade 67
trans,cis,cis-Bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a Prodrug Candidate for the Treatment of Oxaliplatin-Refractory Colorectal Cancer 67
Electrochemical Biosensor Assay of the Interaction between [PtCl(n)(NH(3))(4-n)]((2-n)) (n=0-4) Complexes and ds-DNA 67
Electrochemical, Theoretical and Structural Investigations on the "Butterfly" Co4(CO)8L2(RC2R) (L=CO, PPh3, R=H, Et, Ph) Cluster 66
Studies on Log Po/w of Quinoxaline di-N-Oxides: A Comparison of RP-HPLC Experimental and Predictive Approaches 66
Enhancement of the cytotoxicity of titanocene dichloride by aging in organic co-solvent 66
Targeting and delivery of Pt(II) antiproliferative drugs 65
Molecular and statistical modeling of reduction peak potential and lipophilicity of platinum(IV) complexes 65
Unsymmetric cisplatin-based pt(Iv) conjugates containing a parp-1 inhibitor pharmacophore tested on malignant pleural mesothelioma cell lines 65
Over 100 Years of Research on Cyclopentadienylironcarbonyl Chemistry: Microscale-Integrated Organometallic Experiments 64
Ethynylestradiol-Pt(II) complexes for selective drug targeting 64
Electrochemical Behaviour of Tropone Diiron Pentacarbonyl Complexes Fe2(CO)5[(RC2R)3CO] (R = Et, Me, n-Pr). Formation of a Carbon-Carbon Bond upon Reduction 63
The Microscale Synthesis and Electrochemistry of Low-Valent Mononuclear Complexes (h3-C3H5)Fe(CO)3X (X = I, Br, Cl) 63
Totale 8.714
Categoria #
all - tutte 77.353
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.353


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021656 0 0 0 0 0 27 180 4 189 47 186 23
2021/20221.220 69 20 171 141 57 0 161 28 80 22 214 257
2022/20232.614 186 93 170 65 147 244 55 134 1.377 34 77 32
2023/2024763 54 62 76 14 138 0 136 11 9 4 132 127
2024/20251.763 17 53 99 42 74 188 197 98 389 210 83 313
2025/20263.053 372 318 589 1.103 594 77 0 0 0 0 0 0
Totale 13.504